A 14-year-old girl with schizophrenia started aripiprazole (Abilify) 2 mg and feels very tired; what should be done?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Fatigue in a 14-Year-Old on Aripiprazole 2mg

First, determine if this is sedation from aripiprazole or akathisia presenting as fatigue, then either wait 2-4 weeks for tolerance to develop while providing reassurance, or if akathisia is confirmed, reduce the dose to 1mg daily or switch to a different atypical antipsychotic.

Initial Assessment: Distinguish Sedation from Akathisia

The complaint of "feeling very tired" requires careful evaluation, as this could represent:

  • True sedation: A common side effect of aripiprazole that typically improves with time 1, 2
  • Akathisia masquerading as fatigue: Akathisia can present as restlessness that patients may describe as exhausting or tiring, and is frequently misinterpreted, leading to inappropriate management 3

Key clinical distinction: Ask specifically about inner restlessness, inability to sit still, pacing, or a compulsion to move. If present, this suggests akathisia rather than sedation 4, 3.

Management Strategy Based on Assessment

If True Sedation (No Akathisia Features)

Reassure and observe for 2-4 weeks, as sedation is among the most common side effects in adolescents taking aripiprazole but often improves with continued treatment 1, 5. The drug reaches steady-state by 14 days, and tolerance to sedation typically develops during this period 6, 2.

If sedation persists beyond 4 weeks or is intolerable:

  • Consider dose reduction to 1mg daily, as lower doses may maintain efficacy while reducing side effects in adolescents 7, 5
  • Alternatively, switch to quetiapine or olanzapine, which have different side effect profiles 3

If Akathisia is Present

First-line approach: Lower the aripiprazole dose to 1mg daily while remaining within therapeutic range 3. This is the preferred initial strategy in adolescents, as children and adolescents are at higher risk for extrapyramidal side effects including akathisia compared to adults 3.

If dose reduction is insufficient or not feasible:

  • Add propranolol 10mg two to three times daily, which is the most consistently effective treatment for akathisia 3
  • Monitor carefully, as anticholinergic agents (like benztropine) are notably less effective for akathisia compared to other extrapyramidal side effects 3

Critical pitfall to avoid: Do not increase the aripiprazole dose thinking the fatigue represents worsening psychosis, as akathisia is frequently misinterpreted as psychotic agitation or anxiety, leading to inappropriate dose increases that worsen the condition 3.

Special Considerations in Adolescents

  • Weight-based dosing may be needed: Limited data in children and adolescents suggest that a revised dosing strategy based on weight is indicated in this population 7
  • Higher risk of side effects: Adolescents may experience more frequent side effects than adults, including sedation, which occurred commonly in pediatric trials 1, 5
  • Monitor for other side effects: While managing fatigue, assess for headache, nausea, and weight changes, which are common in adolescent patients 1, 5

Monitoring During Management

  • Reassess in 1-2 weeks after any intervention to determine response 3
  • Document abnormal movements at baseline and every 3-6 months using the Abnormal Involuntary Movement Scale, as up to 50% of youth receiving antipsychotics may experience some form of movement disorder 4
  • Check for suicidality if akathisia is present, as akathisia is associated with increased suicidal ideation 3

When to Consider Alternative Antipsychotics

If the patient fails to respond to dose adjustment and adjunctive treatments, or if side effects remain intolerable, switch to another atypical antipsychotic with lower akathisia risk such as quetiapine or olanzapine 3. These agents have different receptor profiles and may be better tolerated in this specific patient 4, 6.

References

Research

Aripiprazole.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003

Guideline

Treatment Options for Akathisia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.